The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: Implications for coadministration with clopidogrel - Ogilvie, B W; Yerino, P; Kazmi, F (Drug Metab Dispos, 2011)
et al.